Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

OCUL

Ocular Therapeutix, Inc.

Healthcare · USD

Set alert

Price alert · OCUL

All alert types
6.97 USD -0.34 -4.65%
As of Oct 30, 2026 Extended hours 7.03 +0.86%
Bid
6.96 × 2
Ask
6.97 × 2
6.93 Day range 7.38
6.29 52-week range 16.11
YTD
-42.59%
1 year
-41.03%
Open
7.27
Prev close
7.31
Mkt cap
1.53B
Vol
2.63M
Avg vol
3.06M
EPS
-1.40
P/E
0.00
Div yield
0.00%
More statistics
Low
6.93
High
7.38
Forward P/E
-4.71
Beta
0.99
Short ratio
7.60
Inst. own
95.32%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
8.89
200-d avg
9.14
1y target
25.45

5D chart

Chart tools
Interval
1m5m15m30m
OCUL five-day price chart6.346.596.847.097.34Oct 22Oct 23Oct 26Oct 27Oct 28

Financial health

Altman Z-Score

3.03 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -8.5×
FY 2016: -4.6×FY 2017: -2.0×FY 2018: -2.5×FY 2019: -2.1×FY 2020: -8.1×FY 2021: -6.6×FY 2022: -2.7×FY 2023: -4.1×FY 2024: -7.0×FY 2025: -8.5×
FY 2016 5y median -6.6× FY 2025
P/S 43.9×
FY 2016: 110×FY 2017: 66.7×FY 2018: 76.2×FY 2019: 42.3×FY 2020: 72.3×FY 2021: 12.2×FY 2022: 4.2×FY 2023: 6.1×FY 2024: 21.2×FY 2025: 43.9×
FY 2016 5y median 12.2× FY 2025
P/B 3.5×
FY 2016: 4.0×FY 2017: 4.9×FY 2018: 4.2×FY 2019: -49.3×FY 2020: 16.5×FY 2021: 6.1×FY 2022: 6.1×FY 2023: 3.9×FY 2024: 4.3×FY 2025: 3.5×
FY 2016 5y median 4.3× FY 2025
P/FCF -10.5×
FY 2016: -5.8×FY 2017: -2.2×FY 2018: -3.0×FY 2019: -2.2×FY 2020: -23.1×FY 2021: -8.0×FY 2022: -3.4×FY 2023: -4.7×FY 2024: -9.9×FY 2025: -10.5×
FY 2016 5y median -8.0× FY 2025
EV/EBITDA -6.5×
FY 2016: -4.5×FY 2017: -1.7×FY 2018: -2.2×FY 2019: -2.4×FY 2020: -7.4×FY 2021: 168×FY 2022: -2.9×FY 2023: -3.7×FY 2024: -5.9×FY 2025: -6.5×
FY 2016 5y median -3.7× FY 2025
EV/Sales 31.2×
FY 2016: 101×FY 2017: 54.5×FY 2018: 61.5×FY 2019: 43.5×FY 2020: 62.5×FY 2021: 9.8×FY 2022: 3.5×FY 2023: 4.2×FY 2024: 16.2×FY 2025: 31.2×
FY 2016 5y median 9.8× FY 2025
FCF Yield -9.5%
FY 2016: -17.3%FY 2017: -45.8%FY 2018: -33.7%FY 2019: -44.6%FY 2020: -4.3%FY 2021: -12.5%FY 2022: -29.3%FY 2023: -21.4%FY 2024: -10.1%FY 2025: -9.5%
FY 2016 5y median -12.5% FY 2025

Profitability

Gross Margin 87.3%
FY 2016: 76.5%FY 2017: 76.2%FY 2018: 76.6%FY 2019: 45.0%FY 2020: 88.0%FY 2021: 89.9%FY 2022: 91.2%FY 2023: 91.0%FY 2024: 91.2%FY 2025: 87.3%
FY 2016 5y median 91.0% FY 2025
Operating Margin -521.0%
FY 2016: -2296.0%FY 2017: -3220.1%FY 2018: -2970.8%FY 2019: -2029.9%FY 2020: -361.1%FY 2021: -179.3%FY 2022: -152.7%FY 2023: -141.0%FY 2024: -269.6%FY 2025: -521.0%
FY 2016 5y median -179.3% FY 2025
Net Margin -513.2%
FY 2016: -2369.0%FY 2017: -3296.2%FY 2018: -2899.1%FY 2019: -2043.3%FY 2020: -894.3%FY 2021: -15.1%FY 2022: -138.0%FY 2023: -138.1%FY 2024: -303.7%FY 2025: -513.2%
FY 2016 5y median -138.1% FY 2025
ROE -40.6%
FY 2016: -86.0%FY 2017: -242.4%FY 2018: -160.8%FY 2019: 2379.4%FY 2020: -204.5%FY 2021: -7.4%FY 2022: -200.8%FY 2023: -88.6%FY 2024: -61.4%FY 2025: -40.6%
FY 2016 5y median -61.4% FY 2025
ROIC -35.5%
FY 2016: -63.5%FY 2017: -130.2%FY 2018: -89.0%FY 2019: -126.5%FY 2020: -25.7%FY 2021: -43.3%FY 2022: -65.8%FY 2023: -37.7%FY 2024: -41.0%FY 2025: -35.5%
FY 2016 5y median -41.0% FY 2025
ROA -32.9%
FY 2016: -59.7%FY 2017: -114.4%FY 2018: -79.0%FY 2019: -109.7%FY 2020: -59.4%FY 2021: -3.2%FY 2022: -47.6%FY 2023: -32.0%FY 2024: -42.3%FY 2025: -32.9%
FY 2016 5y median -32.9% FY 2025

Growth (YoY)

Revenue -18.7%
FY 2016: 7.8%FY 2017: 1.9%FY 2018: 3.5%FY 2019: 112.4%FY 2020: 311.7%FY 2021: 150.1%FY 2022: 18.3%FY 2023: 13.5%FY 2024: 9.0%FY 2025: -18.7%
FY 2016 FY 2025
Operating Income -57.2%
FY 2016: -13.4%FY 2017: -42.9%FY 2018: 4.5%FY 2019: -45.1%FY 2020: 26.8%FY 2021: -24.2%FY 2022: -0.8%FY 2023: -4.7%FY 2024: -108.5%FY 2025: -57.2%
FY 2016 FY 2025
EPS (diluted) -16.4%
FY 2016: -5.3%FY 2017: -22.2%FY 2018: 28.6%FY 2019: -21.7%FY 2020: -34.0%FY 2021: 61.7%FY 2022: 1.0%FY 2023: -5.2%FY 2024: -19.6%FY 2025: -16.4%
FY 2016 FY 2025
Free Cash Flow -59.5%
FY 2016: -1.1%FY 2017: -63.5%FY 2018: 13.0%FY 2019: -56.1%FY 2020: 31.8%FY 2021: -22.7%FY 2022: 5.1%FY 2023: -20.5%FY 2024: -78.1%FY 2025: -59.5%
FY 2016 FY 2025

Financial Health

Current Ratio 15.4×
FY 2016: 8.4×FY 2017: 3.2×FY 2018: 6.1×FY 2019: 5.0×FY 2020: 9.2×FY 2021: 7.3×FY 2022: 4.1×FY 2023: 6.7×FY 2024: 10.7×FY 2025: 15.4×
FY 2016 5y median 7.3× FY 2025
Quick Ratio 15.3×
FY 2016: 8.4×FY 2017: 3.2×FY 2018: 6.1×FY 2019: 4.9×FY 2020: 9.2×FY 2021: 7.2×FY 2022: 4.1×FY 2023: 6.6×FY 2024: 10.6×FY 2025: 15.3×
FY 2016 5y median 7.2× FY 2025
Debt / Equity 0.1×
FY 2016: 0.3×FY 2017: 0.7×FY 2018: 0.7×FY 2019: -16.3×FY 2020: 0.8×FY 2021: 0.7×FY 2022: 1.8×FY 2023: 0.9×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 2.6×
FY 2016: 0.4×FY 2017: 0.4×FY 2018: 0.5×FY 2019: -0.1×FY 2020: 1.2×FY 2021: -41.4×FY 2022: 0.6×FY 2023: 1.7×FY 2024: 1.8×FY 2025: 2.6×
FY 2016 5y median 1.7× FY 2025
Interest Coverage -22.8×
FY 2016: -25.8×FY 2017: -32.7×FY 2018: -34.0×FY 2019: -14.1×FY 2020: -9.3×FY 2021: -11.7×FY 2022: -11.2×FY 2023: -7.3×FY 2024: -12.7×FY 2025: -22.8×
FY 2016 5y median -11.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31